Dr. Marni C. Wiseman
Dr. Marni C. Wiseman began her Dermatology practice in Winnipeg, Manitoba in 2001. In addition to her responsibilities as an Associate Professor and Section Head of Dermatology at the Faculty of Medicine at the University of Manitoba, Dr. Wiseman spends most of her days at her Private Medical Practice as the Medical Director of SKiNWISE DERMATOLOGY.
Dr. Wiseman’s areas of clinical and research interest include psoriasis, atopic dermatitis, hidradenitis suppuritiva, acne, and aesthetic dermatology. She is a Principal Investigator at Wiseman Dermatology Research and has participated in hundreds of clinical trials.
Dr. Wiseman is a frequent supervisor and mentor for medical students and residents. She is extensively published in areas of inflammatory skin disease, photodermatosis, and cutaneous malignancy.
Dr. Wiseman’s community commitments are extensive and include involvement with the Canadian Dermatology Association Sun Awareness program. She is an editor of the Journal of Cutaneous Medicine and Surgery, and was the chair of the Skin Cancer Disease Site Group at CancerCare Manitoba for 15 years. Dr. Wiseman holds regular outreach skin cancer screening clinics in rural locations in Manitoba, has been featured in many news stories, and regularly presents at meetings and congresses nationally and internationally.
Saturday NOV 13, 2021
Advances in Acne Vulgaris: Updates in topical retinoid therapy
- Describe new developments in topical retinoid treatments for acne vulgaris
- Recognize key considerations around vehicles for topical treatments in dermatology
- Integrate data on safety and efficacy of retinoids into the treatment of acne vulgaris in day-to-day practice
Summary description of the session:
Join us for an international expert panel discussion that will address new advances in topical retinoid treatment of acne vulgaris. A new formulation of a topical retinoid has been developed, incorporating recent developments in vehicle technology, to address shortcomings of older retinoid formulations. Acne experts from the US and Canada will discuss the clinical trial data, the value of this innovation, and how it fits into their day-to-day practice.